Dr. Calvin Willhite is a renowned expert in developmental toxicology and quantitative structure-activity relationships, with a substantial publication record. He has played key roles in influential organizations and committees, including the National Academy's Committee on Toxicology, the U.S. EPA's National Advisory Committee, and the IARC Cancer Chemoprevention Panel. Dr. Willhite is a member of the Society of Toxicology and is featured in notable biographical publications. Currently, he serves as an Associate Expert with Risk Sciences International, contributing to health risk assessments for various chemicals, both man-made and naturally-occurring.

Dr. William Leiss held the NSERC/SSHRC Research Chair in Risk Communication and Public Policy at the Haskayne School of Business, University of Calgary, from 1999 to 2005. He has a substantial consulting background, collaborating with industry and various Canadian government departments on risk communication, risk management, public consultation, and multi-stakeholder consensus-building processes. Dr. Leiss has provided expertise on diverse issues, including pesticides, toxic chemicals, tobacco, prescription drugs, electric & magnetic fields, and genetic engineering. He earned his PhD from the University of California at San Diego.

With 20+ years experience in accounting and 12+ years experience in web development, I spend half of my time as a finance officer and bookkeeper. The other half of my time is spent coding, deploying, consulting and maintaining a variety of management web applications.

Paul Stanish holds a B.Sc. in Chemistry from Carleton University and a Ph.D. in Chemistry and Nanotechnology from the University of Waterloo. His doctoral research focused on energy movement in semiconducting oxides. Paul has experience in analytical chemistry and has developed Android applications for risk management in options trading. He joined Risk Sciences International in 2021, focusing on leveraging emerging tools to modernize client understanding of risk and streamline data culture.

Nawal Farhat is an epidemiologist with expertise in systematic reviews and database analysis. She collaborates with RSI on systematic reviews related to exposure-related health effects. Her doctoral research at the University of Ottawa focused on analyzing electronic medical records to study drug-drug interactions in cardiovascular patients. Nawal holds an MSc in Epidemiology, where she explored the health effects of air pollution in Canadian cities. Her background includes coordinating surveillance systems for communicable diseases at Lebanon's Ministry of Public Health and teaching epidemiology and biostatistics courses.

Since 2002, Mr. McNair has led key aspects of Cerner's Big Data operations, ensuring data quality for over 700 healthcare institutions. His role focuses on using this data for predictive models and decision-support solutions. McNair's career at Cerner began in 1986, where he co-invented Discern Expert®, a real-time decision-support engine used globally. He held positions in regulatory affairs, served as a General Manager, and worked in pharmaceutical roles. McNair is a prominent figure in mathematical modeling, AI, and health finance, with over 100 patents and numerous publications. He's also active in volunteer work and academic pursuits.

Monique Macdonald brings 35 years of experience in office management and financial administration to her role as Office Administrator at RSI. Specializing in stakeholder liaison, data management, and bookkeeping, she also supports sales, marketing, and workshop administration. Monique holds a diploma in Business Administration and Accounting and has a background in both aerial surveying and industry association firms. Additionally, she serves as RSI’s Alternate Security Officer for federal government contracting services.

Dr. Kacew is a distinguished figure in the field of toxicology, holding various prominent editorial positions. Notably, he serves as the Editor-in-Chief of the Journal of Toxicology and Environmental Health, Part A, and the Editor-in-Chief of the Journal of Toxicology and Environmental Health, Part B, Critical Reviews. Dr. Kacew is also the North American Editor for Toxicological and Environmental Chemistry and holds an Associate Editor role in Toxicology and Applied Pharmacology, among others. His extensive publication portfolio includes over 150 papers, reviews, and book chapters, with a focus on general toxicology, including renal, hepatic, and pulmonary toxicology. Additionally, he is a Member of the Board of Trustees for Toxicology Excellence for Risk Assessment (TERA).